Abstract TP59: The Sustained DeyeCOM Sign as a Predictor of Large Vessel Occlusion

Introduction: Rapid imaging in acute stroke is critical and often occurs before full examination. Early, reliable exam findings clarify diagnosis and improve treatment times. Suspected stroke patients typically undergo both acute non-contrast CT and CT Angiogram (CTA). The DeyeCOM sign (conjugate gaze deviation on CT) has been described as a predictor of ischemic stroke with good specificity. In this study, we further evaluate a sustained DeyeCOM sign on both CT and CTA in early prediction of anterior large vessel occlusion (LVO). Methods: We retrospectively reviewed 46 acute stroke code patients between April and June 2017 from the prospective, IRB approved UCSD Stroke Registry. Patients had both CT and CTA as part of their acute stroke work-up as standard of care. DeyeCOM(+) sign was defined as a conjugate gaze deviation on CT or CTA of at least 15 degrees measured by caliper technique on Agfa IMPAX software (v.6.6.1.3525). DeyeCOM(++) was defined as sustained gaze deviation on both CT and CTA. Results: Three groups of patients were observed: 1) gaze deviation on both CT and CTA (DeyeCOM(++)), 2) non-sustained gaze deviation (+ on CT or CTA but not both), and 3) no gaze deviation (DeyeCOM(--)). All patients with DeyeCOM(++) (8/8, 100%) had anterior LVO. Of those with non-sustained gaze deviation, 2/7 (29%) had LVO. No DeyeCOM(--) patients (0/31, 100%) had LVO. Of the DeyeCOM(--) patients, 16/31 (52%) were stroke mimics and 15/31 (48%) had strokes that were not LVO. The specificity and sensitivity of DeyeCOM(++) for LVO was 100% (CI .90-1.0) and 80% (CI .44-.97). The specificity and sensitivity of DeyeCOM(--) for absence of LVO was 100% (CI .69-.10) and 86% (CI .70-.95). Conclusion: In this study, DeyeCOM(++) had 100% specificity for anterior LVO while DeyeCOM(--) had a 100% specificity for absence of LVO. DeyeCOM(++) false positive rates were low. Sustained DeyeCOM, whether positive or negative, is a strong predictor of ultimate diagnosis. These results should support practitioners’ confidence that DeyeCOM(++) reflects LVO stroke and is unlikely to be a mimic and DeyeCOM(--) patients likely do not have LVO. This data point can potentially lead to quicker endovascular treatment times. Further comparisons in this dataset are ongoing and work in a larger data set is needed.